In a groundbreaking shift, young women lead cannabis consumption, prompting companies to revamp products and invest in targeting the female demographic.
FDA's new guidance recommends assessing neurodevelopmental outcomes in neonates up to at least 2 years adjusted age, addressing a critical gap in long-term safety evaluation of medical products for newborns.
FDA approves Avadel Pharmaceuticals' once-nightly dosing sleep disorder drug, Lumryz, for children aged 7 years and older, offering a new option for narcolepsy treatment.
Discover the impact of medication shortages on adults with ADHD and the role of telehealth services in expanding access to diagnosis and treatment. Insights from a recent U.S. study shed light on the prevalence of ADHD and the influence of the COVID-19 pandemic.
Reuters
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.